knowledge -WSS

knowledge

author：entertainment 2025-10-03 00:07:34 - browse：3957

Several amyloid plaques forming between neurons in a brain — Adobe

Expert advisers to the Food and Drug Administration on Friday voted unanimously in favor of expanding the approval of Leqembi, an Alzheimer’s disease treatment from Eisai and Biogen, further clearing the way for what could be the first widely available medicine that delays the disease’s progress.

The group voted 6-0 that an 1,800-patient study of Leqembi confirmed its benefits for patients in the early stages of Alzheimer’s, recommending the FDA widen the drug’s limited approval. The agency, which is not required to follow the suggestions of its advisers, is expected to make a final decision on Leqembi by July 6.

“I thought the clinical results were robust,” said Merit Cudkowicz, a neurologist from Massachusetts General Hospital and one of the experts invited to review Leqembi.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： Report cites 'urgent' need to recruit more diverse clinical trial participants

hotspot

WSS

2 officers injured in shooting in Orlando, police say

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

Report cites 'urgent' need to recruit more diverse clinical trial participants

AMAs digital advisors table RPM coding reform proposal, again

Doctors on social media are being harassed and cyberbullied

Report cites 'urgent' need to recruit more diverse clinical trial participants

leisure time

knowledge

focus

Duchenne breakthrough therapy leaves behind pioneering families

Doctors on social media are being harassed and cyberbullied

Novavax promises a turnaround & Lilly roils the obesity market

Juul documents reveal insider tactics on political lobbying

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Flint parents haunted by uncertainty, fears of lead poisoning

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Congress must protect the remaining independent doctors

Alkermes shareholders re

Why don't Americans have at

Wikipedia

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Late stage cancers on the rise after pandemic delayed screenings

Congress might make insulin pumps more accessible to the blind

Florida officials tell state schools to teach AP Psychology 'in its entirety'

How to ethically and practically extend health care to all

Congress might make insulin pumps more accessible to the blind

knowledge

hotspot

Wikipedia

entertainment